The Business Research Company’s Catheter-Related Bloodstream Infection Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035
LONDON, GREATER LONDON, UNITED KINGDOM, November 10, 2026 /EINPresswire.com/ — The catheter-related bloodstream infection (CRBSI) market is witnessing steady growth driven by increasing healthcare demands and advances in infection control. As hospitals and healthcare providers focus more on preventing complications associated with catheter use, the market is positioned for sustained expansion in the coming years. Let’s explore the current market size, key drivers, major players, and regional insights shaping this vital healthcare segment.
Current Market Size and Future Growth of the Catheter-Related Bloodstream Infection Market
The market for catheter-related bloodstream infections has experienced significant growth recently. It is projected to rise from $1.62 billion in 2025 to $1.71 billion in 2026, reflecting a compound annual growth rate (CAGR) of 6.0%. This historical growth is largely due to the increased use of central venous catheters, a growing incidence of hospital-acquired infections, wider adoption of antibiotic lock therapy, expansion of intensive care units, and improved clinical awareness about CRBSI. Looking ahead, the market is expected to further grow to $2.11 billion by 2030, with a CAGR of 5.3%. This future expansion is fueled by greater investments in infection prevention protocols, rising demand for managing antimicrobial resistance, growth in hospital infection control programs, broader use of combination therapies, and advancements in diagnostic technologies. Key trends that will impact the market include the adoption of advanced antimicrobial lock solutions, increased infection surveillance programs, a strong focus on preventing hospital-acquired infections, expansion of combination antimicrobial therapies, and an emphasis on early diagnosis and timely intervention.
Download a free sample of the catheter-related bloodstream infection market report:
https://thebusinessresearchcompany.com/sample_request?id=68702434&type=smp&name=Catheter-Related%20Bloodstream%20Infection%20Market%20Report%202026&utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Nov_PR
Understanding Catheter-Related Bloodstream Infection and Its Medical Significance
Catheter-related bloodstream infection occurs when bacteria or fungi enter the bloodstream through a catheter, which is a tube inserted into a vein to deliver medications or nutrients. This infection is a serious healthcare-associated condition that can lead to sepsis and other severe complications if not promptly diagnosed and treated. Effective management requires quick identification and intervention to reduce risks and improve patient outcomes.
Hospital-Acquired Infections as a Key Market Driver for Catheter-Related Bloodstream Infection
The increasing prevalence of hospital-acquired infections (HAIs) plays a crucial role in driving the catheter-related bloodstream infection market. HAIs are infections that patients contract during medical treatment in healthcare facilities, typically appearing 48 hours or more after admission. Factors contributing to the rise in HAIs include antimicrobial resistance, insufficient infection control practices, and vulnerable patient populations. Catheter-related bloodstream infections represent a significant portion of HAIs due to their invasive nature and the potential for microbial colonization around indwelling catheters, which pose serious risks to patients. For example, in September 2025, data from the US National Library of Medicine revealed that in 2024, antimicrobial-resistant organisms accounted for 6.6% of infections. Approximately one-third of HAIs were associated with medical devices, and the prevalence of central line-associated bloodstream infections doubled to 0.4%. These trends highlight how the growing incidence of HAIs is propelling demand within the CRBSI market.
View the full catheter-related bloodstream infection market report:
https://thebusinessresearchcompany.com/report/catheter-related-bloodstream-infection-global-market-report?utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Nov_PR
Increased Healthcare Spending as a Catalyst for Market Expansion
Rising healthcare expenditure is another important factor supporting the growth of the catheter-related bloodstream infection market. Healthcare spending encompasses the total resources allocated by individuals, organizations, and governments toward preventing, diagnosing, and treating health conditions. Advances in medical technology, including new diagnostic tools and innovative therapies, often carry higher costs, leading to increased overall healthcare spending. This investment contributes to reducing CRBSI rates by funding preventive strategies, healthcare staff training, monitoring systems, and timely treatment options, ultimately improving patient safety and reducing long-term costs. For instance, in December 2024, the US Centers for Medicare & Medicaid Services reported that healthcare expenditures in the United States grew by 7.5% in 2023, reaching $4.9 trillion—about $14,570 per person. This rising investment in healthcare is a key driver fueling the expansion of the CRBSI market.
Regional Leadership and Market Distribution in Catheter-Related Bloodstream Infections
In 2025, North America held the largest share of the catheter-related bloodstream infection market, reflecting its advanced healthcare infrastructure and high rates of catheter usage. The market analysis also covers several important regions including Asia-Pacific, Southeast Asia, Western Europe, Eastern Europe, South America, the Middle East, and Africa, providing a comprehensive view of global market dynamics and growth opportunities.
The 2026 edition of our market reports now delivers enhanced analytical coverage through market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, plus updated graphics and tables.
Speak With Our Expert:
Saumya Sahay
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: marketing@tbrc.info
The Business Research Company – www.thebusinessresearchcompany.com
Follow Us On:
• LinkedIn: https://in.linkedin.com/company/the-business-research-company“
Oliver Guirdham
The Business Research Company
+44 7882 955267
info@tbrc.info
Visit us on social media:
LinkedIn
Facebook
X
Legal Disclaimer:
EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Media gallery
